Recommendation 3.1: Population-based payment models should use outcomebased population health measures and risk adjustment systems that are designed to support population-specific and community-specific priorities for prevention and health promotion.Recommendation 3.2: If a payment model is based on measures of value that use annual measures of spending, high-value preventive services with multi-year benefits should be paid for through a separate payment mechanism or budget in order to facilitate patient access to the services, to protect against underuse of services, and to enable flexibility in the way preventive services are delivered. 7 Recommendation 6.1: A clinician or other healthcare provider who is taking accountability under an alternative payment model for improving the quality of care for a patient and for controlling the cost of the patient's care should have the flexibility to design or redesign cost-sharing requirements for the patient where necessary to enable and encourage the patient to adhere to a care plan developed through a shared decision-making process.Recommendation 6.2: Providers should be transparent about the quality of care they deliver so that patients can be assured that they are receiving high-quality care under value-based payment systems and benefit designs. Data and Analyses Needed to Develop and Implement Successful Payment ModelsRecommendation 7.1: Data on all of the important clinical and non-clinical factors that can have a significant impact on patient needs and outcomes must be accessible in order to support development and use of valid and reliable risk stratification methodologies in performance measures and alternative payment models.Recommendation 7.2: Linkages must be developed between the information in claims data, the information in electronic health records and registries, and information on patient-reported outcomes in order to provide the analyses needed to improve care and measure performance. Funding should be provided to enable Qualified Entities (which have multi-payer claims data), Qualified Clinical Data Registries (which collect clinical information relating to patient care), and Patient-8 Reported Outcome databases to link their data for specific uses that will benefit patients, payers, and providers and that incorporate appropriate protections to ensure responsible use.Recommendation 7.3: All Electronic Health Record systems should be required to support (a) the creation of custom fields and (b) data retrieval and analysis. Incentives should be created to encourage the development of infrastructure for linking data and there should be penalties for vendors that block data.Recommendation 7.4: Payers and provider organizations should be required to give clinicians access to information on the amounts payers and patients pay for services. Facilitating the Transition to Improved Payment SystemsRecommendation 8.1: Alternative payment models should be implemented using multi-year contracts and/or multi-year performance measures that allow for a shortterm peri...
A survey of PGY1 and PGY2 pharmacy residents revealed that about one sixth of respondents entering the job market were having difficulty finding a position before finishing residency training and that most respondents were satisfied with their residency experience.
To ensure succession planning within the ranks of nurse managers meet current and projected nursing management needs and organizational goals, we developed and implemented a nurse manager residency program at our hospital. By identifying, supporting, and mentoring clinical experts who express a desire and display an aptitude for nursing leadership, we are graduating individuals who can transition to a nurse manager position with greater ease and competence.
Warfarin, a vitamin K antagonist, is an oral anticoagulant approved for the prevention and treatment of thrombosis and embolism.Due to long half-lives of vitamin K-dependent clotting factors II, VII, IX, and X, most patients do not have a stable INR until five days after warfarin initiation. Warfarin has several shortcomings, including multiple food-drug interactions and activity monitoring through blood testing for the international normalized ratio (INR). Previous studies have shown that pharmacist-managed anticoagulation has significantly decreased the length of hospital stay and the number of patients receiving excessive anticoagulation therapy. These studies showed that bleeding-related readmissions were reduced at one-month and three-month intervals under pharmacist-managed therapy. 1An opt-in, pharmacist-managed warfarin protocol went into hospital-wide effect September 1, 2010 at the University of Kansas Hospital (KUH). OBJECTIVES METHODS RESULTS RESULTS CONCLUSIONS STUDY LIMITATIONSReferences:1. Dager WE, Branch JM, King JH et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.